Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Algernon launches new clinical research program for ifenprodil in pancreatic cancer

June 4, 2021

Monopar and the National University of Singapore collaborate on development of MNPR-202

June 4, 2021

Hoth Therapeutics reports preclinical data for novel HT-KIT candidate

June 4, 2021

Suzhou Zelgen Biosciences synthesizes new GTPase KRAS mutant inhibitors

June 3, 2021

Nurix Therapeutics presents new PROTACs

June 3, 2021

First patient enrolled in phase Ib study of LB-100 for treatment of small cell lung cancer

June 3, 2021

MCAD as novel therapeutic target for glioblastoma

June 2, 2021

Valo Early Discovery identifies new HDAC8 inhibitors

June 2, 2021

Revolution Medicines discloses SOS1 inhibitors

June 2, 2021

Viracta initiates global pivotal study of nanatinostat plus valganciclovir in EBV+ lymphoma

June 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...